SGNTUC-022 Tucatinib, trastuzumab, ramucirumab, and paclitaxel versus paclitaxel and ramucirumab in previously treated HER2+ gastroesophageal cancer
Clinical Trial Grant
Awarded By
Seattle Genetics, Inc
Start Date
June 19, 2020
End Date
October 26, 2023
Awarded By
Seattle Genetics, Inc
Start Date
June 19, 2020
End Date
October 26, 2023